PeriCor LLC

Bethesda, MD · Medtech · Private

Minimally-invasive pericardial access tool for delivering cardiac pacing and defibrillation leads to the epicardial surface of the heart via percutaneous approach under endoscopic visualization

Grants
$4.3M
6 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
1
0 granted · 1 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · PeriPath: A Novel Pericardial Access Tool for Epicardial Pacing and Defibrillation$224,730
Federal grantDepartment of Health and Human Services · Phase I · PeriPath: A Novel Pericardial Access Tool for Epicardial Pacing and Defibrillation$224,730
Federal grantDepartment of Health and Human Services · Phase II · PeriPath: A Single Incision Delivery Tool for Epicardial Pacing and Defibrillation: Phase 2$914,055
Federal grantDepartment of Health and Human Services · Phase II · PeriPath: A Single Incision Delivery Tool for Epicardial Pacing and Defibrillation: Phase 2$1,764,433
Federal grantDepartment of Health and Human Services · Phase II · PeriPath: A Single Incision Delivery Tool for Epicardial Pacing and Defibrillation: Phase 2$850,378
Federal grantDepartment of Health and Human Services · Phase I · PeriScope: A Novel Videoscope and Toolkit to Enable Fluoro-free Pericardial Access for Epicardial Ablation$295,922
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
938OPTIVA FERTILITY, INC.—$3.0M
939Prior Knowledge, Inc.—$2.0M
940METFORA LLC——
941PeriCor LLC——
942Imbio, LLC—$1.1M
943VISTA ENGINEERING, INC.——
944Innovoyce LLC—$9.9M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 1
  • Percutaneous Access Kit And Uses Thereofapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.